The United States Court of Appeals for the Federal Circuit (CAFC) on Tuesday affirmed an invalidity decision of the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) in Immunex Corporation v. Sanofi-Aventis U.S. LLC. Considering the intrinsic and extrinsic evidence, the C Read More>>
Categories Courts, Federal Circuit, IP News, IPWatchdog Articles, Litigation, Patents, USPTO, CAFC, claim construction, intellectual property, inter partes review, IPR, obviousness, patent, patent office, Patent Trial and Appeal Board, PTAB